Acurex Pharmaceuticals Partners with New to The Street for Media Campaign
New to The Street TVApril 17, 20251 min4,914 views
9 connections·9 entities in this video→Acurex Pharmaceuticals and New to The Street Partnership
- 🤝 Acurex Pharmaceuticals (NASDAQ: ACXP) has entered into a renewed media partnership with New to The Street.
- 🎯 The partnership aims to spotlight Acurex's work in combating drug-resistant infections.
Acurex's Innovative Antibiotics
- 🔬 Acurex is developing a groundbreaking new class of antibiotics specifically targeting Gram-positive bacteria.
- ⚠️ This innovative approach is gaining national attention due to the critical global issue of antimicrobial resistance.
Media Campaign Details
- 📺 A six-month campaign will feature exclusive interviews with industry leaders, including President and CEO David Luchi.
- 📺 Airing on platforms like Fox Business, Bloomberg Television, and New to the Street's YouTube channel, the campaign will reach millions of investors and healthcare professionals.
- 📈 The campaign includes over 300 national commercials, earned media placements, and Times Square billboards to amplify the Acurex story.
Knowledge graph9 entities · 9 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover · drag to explore
9 entities
Chapters1 moments
Key Moments
Transcript5 segments
Full Transcript
Topics11 themes
What’s Discussed
Acurex PharmaceuticalsNew to The StreetMedia PartnershipDrug-resistant infectionsAntibioticsGram-positive bacteriaAntimicrobial resistanceDavid LuchiFox BusinessBloomberg TelevisionNASDAQ: ACXP
Smart Objects9 · 9 links
Companies· 4
Location· 1
Concepts· 2
Person· 1
Media· 1